Tempus Pixel vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Tempus Pixel
VS
by Tempus AI, Inc.

AI Verdict

Tempus Pixel is a comprehensive, multi-modality medical imaging analysis platform designed to enhance diagnostic accuracy and workflow across various specialties including cardiology, oncology, and neurology. In contrast, Tempus ECG-AF is a specialized AI algorithm focused solely on analyzing 12-lead ECGs to predict the risk of atrial fibrillation in a specific patient population. While both leverage AI in cardiology, Pixel serves broader diagnostic imaging needs, whereas ECG-AF provides a targeted risk assessment tool.

Choose Tempus Pixel if…

Choose Tempus Pixel if your organization requires a comprehensive, AI-powered medical imaging analysis platform to enhance diagnostic accuracy and streamline workflows across multiple specialties like cardiology, oncology, and neurology. This cloud-based solution is ideal for radiology departments seeking multi-modality support, real-time collaboration, and advanced quantitative analysis for MRI, CT, X-ray, and ultrasound images.

View Tempus Pixel →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your clinical practice focuses on proactively identifying older adult patients at risk for developing new-onset atrial fibrillation within the next year. This FDA-cleared AI algorithm is specifically designed for 12-lead ECG analysis in patients aged 65 or older without pre-existing AF, enabling earlier intervention and follow-up for this high-risk population.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Tempus Pixel Tempus ECG-AF
Pricing Unknown Contact vendor
Deployment Cloud-based Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tempus Pixel

Tempus Pixel, being cloud-based and web-accessible via a standard browser, offers a highly flexible and accessible platform for radiologists and clinicians. Its features like real-time collaboration and 3D visualization further enhance an interactive user experience for complex imaging analysis.

Clinical Value

Tempus ECG-AF

Tempus ECG-AF provides a highly specific and clinically impactful predictive capability by identifying patients at increased risk of developing atrial fibrillation/flutter within 12 months, based on a large training dataset. This FDA-cleared tool supports earlier identification and follow-up for a significant health condition, offering a clear, measurable clinical outcome.

Pricing & Value

Tempus ECG-AF

While both tools require contacting the vendor for pricing, Tempus ECG-AF explicitly details CMS reimbursement availability with specific CPT codes (0764T and 0765T) and a Medicare rate of $128.90, effective January 1, 2025. This transparency regarding reimbursement significantly enhances its value proposition and financial viability for healthcare providers.

Enterprise Readiness

Tie

Both Tempus Pixel and Tempus ECG-AF are from Tempus, are FDA-cleared, HIPAA compliant, and designed to integrate with existing healthcare systems like PACS, EHR, and RIS. Both demonstrate strong adherence to regulatory and interoperability standards essential for enterprise deployment.

Innovation

Tempus ECG-AF

Tempus ECG-AF stands out for its innovative application of AI to predict a future medical event (AF within 12 months) using a common diagnostic test (12-lead ECG). This predictive capability represents a significant advancement in proactive risk identification and preventative care, moving beyond traditional diagnostic enhancement.

Support & Docs

Tempus Pixel

Tempus Pixel benefits from a publicly available Service-Level Agreement that details specific support channels (Phone, Email, Live Chat), business hours, and guaranteed response times, including a 5-minute response for live chat. While Tempus ECG-AF provides general contact information for support, it lacks the detailed service level commitments found for Pixel.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Tempus Pixel Tempus ECG-AF
Name Tempus Pixel Tempus ECG-AF
Company Tempus (formerly Arterys) Tempus AI, Inc.
Description AI-powered, cloud-based medical imaging analysis platform that enhances diagnostic accuracy and workflow efficiency for radiologists and clinicians across cardiology, oncology, and neurology. FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Tagline The future of precision medicine that only human + AI can achieve. Advancing precision medicine through the practical application of artificial intelligence in healthcare.
Primary Application AI-powered analysis of multi-modality medical imaging (MRI, CT, X-ray, ultrasound) with 3D visualization and automated reporting. AI-based algorithm for 12-lead ECG analysis to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months.
Target Specialties Cardiology, Oncology, Radiology Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Tempus Pixel and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tempus Pixel is an AI-powered, cloud-based platform for analyzing various medical images (MRI, CT, X-ray, ultrasound) to enhance diagnostic accuracy and workflow across cardiology, oncology, and neurology. In contrast, Tempus ECG-AF is an FDA-cleared AI-based algorithm specifically designed to analyze 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within the next 12 months.
Tempus Pixel supports multi-modality medical imaging data, including MRI, CT, X-ray, and ultrasound. Tempus ECG-AF specifically analyzes 12-lead ECG recordings.
Tempus Pixel is designed to support Cardiology, Oncology, and Radiology, enhancing diagnostic capabilities for clinicians in these areas. Tempus ECG-AF is primarily aimed at Cardiology, Geriatrics, and Internal Medicine, focusing on early identification of AF risk in specific patient populations.
Yes, Tempus ECG-AF is intended for patients aged 65 or older who do not have pre-existing atrial fibrillation/flutter, pacemakers, ICDs, or a history of recent cardiac surgery within the preceding 30 days. Its results should be interpreted in conjunction with other diagnostic information and clinical history, and not as the sole basis for diagnosis or treatment.
For Tempus ECG-AF, CMS reimbursement is available through CPT codes 0764T and 0765T, mapping to APC 5734 with a Medicare rate of $128.90, effective January 1, 2025. Pricing for Tempus Pixel requires contacting the vendor for a quote.
Tempus Pixel provides AI-powered analysis, automated reporting, 3D visualization, and quantitative analysis of medical images to aid diagnosis. Tempus ECG-AF provides an assessment of increased risk for developing new onset Atrial Fibrillation (AF) within 12 months for eligible patients based on 12-lead ECG analysis.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.